Demystifying the Global Health Workforce

 

In the latest episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims, Chief Marketing & Communications Officer at TruMerit (formerly CGFNS International, Inc.), is joined by Jim Campbell, Director of Health Workforce at the World Health Organization (WHO), and Peter Preziosi, President & CEO of TruMerit. Together, they explore pressing global nursing workforce challenges, the upcoming State of the World’s Nursing Report, and strategies for strengthening health systems worldwide.

Jim Campbell highlights the WHO Global Strategy on Health Workforce 2030, emphasizing the need for investment in workforce education, optimizing existing resources, and improving global workforce data to ensure universal health coverage. He also discusses the impact of COVID-19, which accelerated innovation in digital health and workforce policies but also exposed critical shortages and funding gaps.

Peter Preziosi introduces True Merit’s focus on care model evolution, ethical recruitment, and career mobility. He shares insights on their initiatives, including a global rehabilitation certification for nurses and the evaluation of ethical recruitment standards to align with WHO’s Global Code of Practice on International Recruitment. Both guests stress the urgency of addressing workforce shortages, ensuring fair recruitment practices, and adapting education to prepare healthcare professionals for the future.

As the healthcare landscape evolves, this episode underscores the importance of global collaboration, policy innovation, and investment in nursing leadership to sustain a resilient workforce.

Tune in to the full episode at trumerit.org/podcast or on your favorite podcast platform.

Follow Along For More Episodes!

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…